Three tetracyclines, including one with a narrow spectrum and another with a broad spectrum, to overcome tetracycline resistance.
New ARTs include a first-in-class postattachment inhibitor and fixed-dose combinations that provide complete drug regimens.
New antimicrobials for influenza, malaria, onchocerciasis, smallpox, and more.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. FDA Drug Approvals: Infectious Disease — Year in Review 2018 - Medscape - Jan 18, 2019.